---
document_datetime: 2025-12-02 06:31:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/olysio.html
document_name: olysio.html
version: success
processing_time: 0.1190557
conversion_datetime: 2025-12-26 16:50:34.568059
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Olysio

[RSS](/en/individual-human-medicine.xml/66495)

##### Withdrawn

This medicine's authorisation has been withdrawn

simeprevir Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Olysio](#news-on)
- [More information on Olysio](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 1 May 2018, the European Commission withdrew the marketing authorisation for Olysio (simeprevir) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Janssen-Cilag International NV, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Olysio was granted marketing authorisation in the EU on 14 May 2014 for the treatment of chronic hepatitis C (CHC) in adult patients, in combination with other medicinal products. The marketing authorisation was initially valid for a 5-year period.

The European Public Assessment Report (EPAR) for Olysio is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Olysio : EPAR - Summary for the public

English (EN) (548.55 KB - PDF)

**First published:** 04/06/2014

**Last updated:** 23/05/2018

[View](/en/documents/overview/olysio-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-226)

български (BG) (631.17 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/bg/documents/overview/olysio-epar-summary-public_bg.pdf)

español (ES) (545.76 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/es/documents/overview/olysio-epar-summary-public_es.pdf)

čeština (CS) (612.79 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/cs/documents/overview/olysio-epar-summary-public_cs.pdf)

dansk (DA) (544.06 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/da/documents/overview/olysio-epar-summary-public_da.pdf)

Deutsch (DE) (549.52 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/de/documents/overview/olysio-epar-summary-public_de.pdf)

eesti keel (ET) (542.55 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/et/documents/overview/olysio-epar-summary-public_et.pdf)

ελληνικά (EL) (636.55 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/el/documents/overview/olysio-epar-summary-public_el.pdf)

français (FR) (547.32 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/fr/documents/overview/olysio-epar-summary-public_fr.pdf)

hrvatski (HR) (566.73 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/hr/documents/overview/olysio-epar-summary-public_hr.pdf)

italiano (IT) (545.35 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/it/documents/overview/olysio-epar-summary-public_it.pdf)

latviešu valoda (LV) (612.55 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/lv/documents/overview/olysio-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (573.19 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/lt/documents/overview/olysio-epar-summary-public_lt.pdf)

magyar (HU) (607.91 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/hu/documents/overview/olysio-epar-summary-public_hu.pdf)

Malti (MT) (615.5 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/mt/documents/overview/olysio-epar-summary-public_mt.pdf)

Nederlands (NL) (545.49 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/nl/documents/overview/olysio-epar-summary-public_nl.pdf)

polski (PL) (612.66 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/pl/documents/overview/olysio-epar-summary-public_pl.pdf)

português (PT) (545.33 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/pt/documents/overview/olysio-epar-summary-public_pt.pdf)

română (RO) (572.83 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/ro/documents/overview/olysio-epar-summary-public_ro.pdf)

slovenčina (SK) (612.97 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/sk/documents/overview/olysio-epar-summary-public_sk.pdf)

slovenščina (SL) (604.67 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/sl/documents/overview/olysio-epar-summary-public_sl.pdf)

Suomi (FI) (543.74 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/fi/documents/overview/olysio-epar-summary-public_fi.pdf)

svenska (SV) (544.08 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/sv/documents/overview/olysio-epar-summary-public_sv.pdf)

Olysio : EPAR - Risk-management-plan summary

English (EN) (555.54 KB - PDF)

**First published:** 04/06/2014

**Last updated:** 23/05/2018

[View](/en/documents/rmp-summary/olysio-epar-risk-management-plan-summary_en.pdf)

## Product information

Olysio : EPAR - Product Information

English (EN) (1.15 MB - PDF)

**First published:** 04/06/2014

**Last updated:** 23/05/2018

[View](/en/documents/product-information/olysio-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-719)

български (BG) (2.23 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/bg/documents/product-information/olysio-epar-product-information_bg.pdf)

español (ES) (1.18 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/es/documents/product-information/olysio-epar-product-information_es.pdf)

čeština (CS) (1.84 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/cs/documents/product-information/olysio-epar-product-information_cs.pdf)

dansk (DA) (1.19 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/da/documents/product-information/olysio-epar-product-information_da.pdf)

Deutsch (DE) (1.22 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/de/documents/product-information/olysio-epar-product-information_de.pdf)

eesti keel (ET) (1.12 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/et/documents/product-information/olysio-epar-product-information_et.pdf)

ελληνικά (EL) (2.33 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/el/documents/product-information/olysio-epar-product-information_el.pdf)

français (FR) (1.14 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/fr/documents/product-information/olysio-epar-product-information_fr.pdf)

hrvatski (HR) (1.22 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/hr/documents/product-information/olysio-epar-product-information_hr.pdf)

íslenska (IS) (1.17 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/is/documents/product-information/olysio-epar-product-information_is.pdf)

italiano (IT) (1.12 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/it/documents/product-information/olysio-epar-product-information_it.pdf)

latviešu valoda (LV) (1.78 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/lv/documents/product-information/olysio-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.19 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/lt/documents/product-information/olysio-epar-product-information_lt.pdf)

magyar (HU) (1.85 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/hu/documents/product-information/olysio-epar-product-information_hu.pdf)

Malti (MT) (1.97 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/mt/documents/product-information/olysio-epar-product-information_mt.pdf)

Nederlands (NL) (1.21 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/nl/documents/product-information/olysio-epar-product-information_nl.pdf)

norsk (NO) (1.2 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/no/documents/product-information/olysio-epar-product-information_no.pdf)

polski (PL) (1.9 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/pl/documents/product-information/olysio-epar-product-information_pl.pdf)

português (PT) (1.2 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/pt/documents/product-information/olysio-epar-product-information_pt.pdf)

română (RO) (1.23 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/ro/documents/product-information/olysio-epar-product-information_ro.pdf)

slovenčina (SK) (1.87 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/sk/documents/product-information/olysio-epar-product-information_sk.pdf)

slovenščina (SL) (1.86 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/sl/documents/product-information/olysio-epar-product-information_sl.pdf)

Suomi (FI) (1.09 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/fi/documents/product-information/olysio-epar-product-information_fi.pdf)

svenska (SV) (1.16 MB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/sv/documents/product-information/olysio-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** PSUSA/00010255/201705 08/02/2018

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Olysio : EPAR - All Authorised presentations

English (EN) (473.45 KB - PDF)

**First published:** 04/06/2014

**Last updated:** 23/05/2018

[View](/en/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-799)

български (BG) (494.22 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/bg/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_bg.pdf)

español (ES) (472.79 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/es/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_es.pdf)

čeština (CS) (486.06 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/cs/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (473.7 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/da/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (473.71 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/de/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (473.48 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/et/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (493.72 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/el/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_el.pdf)

français (FR) (473.61 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/fr/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (473.63 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/hr/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (472.72 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/is/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_is.pdf)

italiano (IT) (474.2 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/it/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (487.42 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/lv/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (474.24 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/lt/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (487.25 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/hu/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (486.95 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/mt/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (472.89 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/nl/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (472.92 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/no/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_no.pdf)

polski (PL) (486.5 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/pl/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_pl.pdf)

português (PT) (473.15 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/pt/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_pt.pdf)

română (RO) (472.56 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/ro/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (486.79 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/sk/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (485.7 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/sl/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (472.83 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/fi/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (472.91 KB - PDF)

**First published:**

04/06/2014

**Last updated:**

23/05/2018

[View](/sv/documents/all-authorised-presentations/olysio-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Olysio Active substance simeprevir International non-proprietary name (INN) or common name simeprevir Therapeutic area (MeSH) Hepatitis C, Chronic Anatomical therapeutic chemical (ATC) code J05AE14

### Pharmacotherapeutic group

Antivirals for systemic use

### Therapeutic indication

Olysio is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adult patients.

For hepatitis C virus (HCV) genotype specific activity.

## Authorisation details

EMA product number EMEA/H/C/002777 Marketing authorisation holder

Janssen-Cilag International NV

Turnhoutseweg 30

Opinion adopted 20/03/2014 Marketing authorisation issued 14/05/2014 Withdrawal of marketing authorisation 01/05/2018 Revision 13

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Olysio : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (654.3 KB - PDF)

**First published:** 02/03/2015

**Last updated:** 23/05/2018

[View](/en/documents/procedural-steps-after/olysio-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Olysio-H-C-1438-A20-2777-0019 : EPAR - Assessment Report - Article 20

Adopted

Reference Number: EMA/103226/2017

English (EN) (954.77 KB - PDF)

**First published:** 13/03/2017

**Last updated:** 23/05/2018

[View](/en/documents/variation-report/olysio-h-c-1438-a20-2777-0019-epar-assessment-report-article-20_en.pdf)

Olysio : EPAR - Scientific Conclusion

English (EN) (538.81 KB - PDF)

**First published:** 13/03/2017

**Last updated:** 23/05/2018

[View](/en/documents/scientific-conclusion/olysio-epar-scientific-conclusion_en.pdf)

[Other languages (22)](#file-language-dropdown-608)

български (BG) (687.46 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/bg/documents/scientific-conclusion/olysio-epar-scientific-conclusion_bg.pdf)

español (ES) (530.79 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/es/documents/scientific-conclusion/olysio-epar-scientific-conclusion_es.pdf)

čeština (CS) (87.91 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/cs/documents/scientific-conclusion/olysio-epar-scientific-conclusion_cs.pdf)

dansk (DA) (532.07 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/da/documents/scientific-conclusion/olysio-epar-scientific-conclusion_da.pdf)

Deutsch (DE) (542.71 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/de/documents/scientific-conclusion/olysio-epar-scientific-conclusion_de.pdf)

eesti keel (ET) (528.43 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/et/documents/scientific-conclusion/olysio-epar-scientific-conclusion_et.pdf)

ελληνικά (EL) (698.83 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/el/documents/scientific-conclusion/olysio-epar-scientific-conclusion_el.pdf)

français (FR) (530.89 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/fr/documents/scientific-conclusion/olysio-epar-scientific-conclusion_fr.pdf)

hrvatski (HR) (572.64 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/hr/documents/scientific-conclusion/olysio-epar-scientific-conclusion_hr.pdf)

italiano (IT) (538.07 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/it/documents/scientific-conclusion/olysio-epar-scientific-conclusion_it.pdf)

latviešu valoda (LV) (664.34 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/lv/documents/scientific-conclusion/olysio-epar-scientific-conclusion_lv.pdf)

lietuvių kalba (LT) (575.28 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/lt/documents/scientific-conclusion/olysio-epar-scientific-conclusion_lt.pdf)

magyar (HU) (616.82 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/hu/documents/scientific-conclusion/olysio-epar-scientific-conclusion_hu.pdf)

Malti (MT) (649.44 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/mt/documents/scientific-conclusion/olysio-epar-scientific-conclusion_mt.pdf)

Nederlands (NL) (537.08 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/nl/documents/scientific-conclusion/olysio-epar-scientific-conclusion_nl.pdf)

polski (PL) (648.48 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/pl/documents/scientific-conclusion/olysio-epar-scientific-conclusion_pl.pdf)

português (PT) (538.2 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/pt/documents/scientific-conclusion/olysio-epar-scientific-conclusion_pt.pdf)

română (RO) (576.84 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/ro/documents/scientific-conclusion/olysio-epar-scientific-conclusion_ro.pdf)

slovenčina (SK) (631.52 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/sk/documents/scientific-conclusion/olysio-epar-scientific-conclusion_sk.pdf)

slovenščina (SL) (650.63 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/sl/documents/scientific-conclusion/olysio-epar-scientific-conclusion_sl.pdf)

Suomi (FI) (528.94 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/fi/documents/scientific-conclusion/olysio-epar-scientific-conclusion_fi.pdf)

svenska (SV) (536.57 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

23/05/2018

[View](/sv/documents/scientific-conclusion/olysio-epar-scientific-conclusion_sv.pdf)

Olysio-EMEA-H-C-PSUSA-00010255-201411 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/484307/2015

English (EN) (527.82 KB - PDF)

**First published:** 25/09/2015

**Last updated:** 23/05/2018

[View](/en/documents/scientific-conclusion/olysio-emea-h-c-psusa-00010255-201411-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Olysio : EPAR - Public assessment report

Adopted

English (EN) (3.6 MB - PDF)

**First published:** 04/06/2014

**Last updated:** 23/05/2018

[View](/en/documents/assessment-report/olysio-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Olysio

Adopted

Reference Number: EMA/CHMP/137969/2014

English (EN) (540.38 KB - PDF)

**First published:** 21/03/2014

**Last updated:** 23/05/2018

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-olysio_en.pdf)

#### News on Olysio

[Direct-acting antivirals for hepatitis C: EMA confirms recommendation to screen for hepatitis B](/en/news/direct-acting-antivirals-hepatitis-c-ema-confirms-recommendation-screen-hepatitis-b) 16/12/2016

[PRAC warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C](/en/news/prac-warns-risk-hepatitis-b-re-activation-direct-acting-antivirals-hepatitis-c) 02/12/2016

[World Hepatitis Day - European Medicines Agency uses regulatory tools to facilitate patient access to innovative medicines](/en/news/world-hepatitis-day-european-medicines-agency-uses-regulatory-tools-facilitate-patient-access-innovative-medicines) 25/07/2014

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 March 2014](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-17-20-march-2014) 21/03/2014

#### More information on Olysio

- [EMEA-000625-PIP01-09-M03 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000625-pip01-09-m03)
- [Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free) - referral](/en/medicines/human/referrals/direct-acting-antivirals-indicated-treatment-hepatitis-c-interferon-free)

**This page was last updated on** 23/05/2018

## Share this page

[Back to top](#main-content)